Clearside Biomedical Inc reports results for the quarter ended in September - Earnings Summary

Clearside Biomedical,

09/11/2022 14:32

* Clearside Biomedical Inc  CLSD.OQ  reported a quarterly
adjusted
loss of 13 cents​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of 3 cents per share.
    * Revenue fell 91.3% to $266.00 thousand from a year ago;
analysts
expected $6.52 million. 
    * Clearside Biomedical Inc's reported EPS for the quarter
was a
loss of 13 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearside Biomedical Inc shares had risen by 23.9% this
quarter and lost 49.1% so far this year.
    * The company reported a quarterly loss of $7.83 million.
    * Wall Street's median 12-month price target for Clearside
Biomedical Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
9 at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.03          -0.13          Missed
 Jun. 30 2022      -0.13          -0.13          Met
 Mar. 31 2022      -0.08          -0.13          Missed
 Dec. 31 2021      0.16           0.31           Beat